Skip to main content
. 2009 Sep 21;27(31):5124–5130. doi: 10.1200/JCO.2009.22.0467

Fig 3.

Fig 3.

(A) Cumulative incidence of recurrence in 254 patients who underwent complete resection of rectal cancer and chemoradiotherapy, according to treatment group, National Surgical Adjuvant Breast and Bowel Project R-03 (NSABP R-03) trial. (B) Cumulative incidence of local recurrence in 254 patients who underwent complete resection of rectal cancer and chemoradiotherapy, according to treatment group, NSABP R-03.